Results 111 to 120 of about 15,364 (179)

Correction: Dhillon et al. Molecular Insights and Therapeutic Advances in Low-Risk Myelodysplastic Neoplasms: A Clinical Review. <i>Cancers</i> 2025, <i>17</i>, 3610. [PDF]

Cancers (Basel)
Dhillon V, Maciejewski J, Balasubramanian SK.   +2 more
europepmc   +1 more source

Successful treatment of refractory cancer therapy-induced thrombocytopenia in a breast cancer patient using romiplostim N01: A case report. [PDF]

Medicine (Baltimore)
Liu P, Dong E, Jiang Y, Chen L, Xie B, Ling J.   +5 more
europepmc   +1 more source

Rilzabrutinib in immune thrombocytopenia: a targeted, patient-centered alternative to conventional therapies. [PDF]

Ann Med Surg (Lond)
Afridi H, Qazi K, Rizvi MA, Nasir R, Mahato RK.   +4 more
europepmc   +1 more source

Primary Sjögren's syndrome-associated immune thrombocytopenia: from pathogenesis to treatment. [PDF]

Front Immunol
Liu C, Zheng Z, He T, Zhang G, Fu G.
europepmc   +1 more source

Relationship between thromboembolic events and thrombopoietin receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System and the Japanese Adverse Drug Event Report. [PDF]

BMJ Open
Huang X, Liao X, Huang Y, Zhang C, Wang Z, Yu L.   +5 more
europepmc   +1 more source

Successful Reswitching of Thrombopoietin Receptor Agonists: Two Cases of Immune Thrombocytopenia and Severe Aplastic Anemia. [PDF]

Intern Med
Itoh K, Otsuki N, Suzuki Y, Kiriba C, Kuwata A, Tsutani H, Iwasaki H, Mitsuke Y.   +7 more
europepmc   +1 more source

Avatrombopag and Platelet Recovery in Sepsis-Associated Thrombocytopenia: A Retrospective Observational Cohort Study. [PDF]

Clin Appl Thromb Hemost
Shi N, He J, Xu Q, Zhao X, Bao Y, He D, Li Y, Hu H, Zeng Z, Yu R, Wei Q.   +10 more
europepmc   +1 more source

Original Versus Generic Eltrombopag in Patients with Immune Thrombocytopenia: A Prospective Multi-Center Experience on Efficacy and Safety. [PDF]

J Clin Med
Çelik S, Karabulut ZT, Selim C, Çiftçiler R, Yıldız A, Yaman S, Pınar İE, Eroğlu Küçükdiler AH, Açar NG, Şentürk Yıkılmaz A, Demircan V, Keskin D, Açar İH, Kırcalı E, Kurt Yüksel M.   +14 more
europepmc   +1 more source

Combination of anti-CD20 and hetrombopag in relapsed/refractory immune thrombocytopenia: a case series. [PDF]

Front Med (Lausanne)
Zhang X, Li Y, Guo Y, Zhou X, Lin F, Wang Y, Xing L.   +6 more
europepmc   +1 more source